Genix LLLT Therapeutic Cap for Alopecia

N/A

Waitlist Available

Led By Adam Bodian, MD

Research Sponsored by Kiierr International, LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 weeks

Summary

The purpose of this research is to study the safety and effectiveness of a light therapy device for human hair growth. This device, called the GENIX, is a type of cold, or non-heat producing light emitting diode (LED) that will emit light on the hair growth cells within and around the hair follicle. When these cells do not function properly, one may experience common problems such as baldness and thinning or brittle hair. The application of a special category of low-level non-laser light to be studied in the project may cause an increase in essential nutrients to the damaged hair follicles and skin cells, leading to a reduction in hair loss and in some cases, possibly leading to re-growth.

Eligible Conditions

Balding
Hair Loss
Alopecia
Male Pattern Baldness

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Terminal Hair Growth

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Genix LLLT Therapeutic CapActive Control1 Intervention

This is a low-level light device containing 150, 650 nanometer LEDs and 50, 940 nanometer LEDs of equal energy output, fixed at 10 milliwatts in a low profile helmet.

Group II: Sham Non-therapeutic Placebo CapPlacebo Group1 Intervention

Sham Placebo Cap low profile helmet containing no low-level light.

Do I qualify?Apply below to find out